Accendra Health CFO Surrenders 4,265 Shares for Taxes

Accendra Health Inc. (ACH) EVP & CFO Leon Jonathan A reported 4,265 shares surrendered to the issuer on September 23, 2026, to satisfy tax-withholding obligations in connection with vesting of restricted stock.

Rhea-AI Filing Summary

Accendra Health Inc. (ACH) EVP & CFO Leon Jonathan A reported 4,265 shares surrendered to the issuer on September 23, 2026, to satisfy tax-withholding obligations in connection with vesting of restricted stock. The reported price was $0.85 per share, and he held 286,268 shares directly following the transaction. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Tax Withholding: 4,265 shares

Tax Withholding 1 txn

Insider Leon Jonathan A

Role EVP & CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	4,265	$0.85	$4K

Holdings After Transaction: Common Stock — 286,268 shares (Direct)

Footnotes (1)

1. F1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Key Figures

Shares surrendered for tax withholding: 4,265 shares Reported price per share: $0.85 per share Shares held directly following transaction: 286,268 shares

3 metrics

Shares surrendered for tax withholding 4,265 shares September 23, 2026; in connection with restricted-stock vesting

Reported price per share $0.85 per share September 23, 2026 transaction

Shares held directly following transaction 286,268 shares Following the September 23, 2026 transaction

Key Terms

restricted stock, vesting, tax withholding obligations

3 terms

restricted stock financial

"vesting of restricted stock granted to the Reporting Person"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

vesting financial

"in connection with vesting of restricted stock"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

tax withholding obligations financial

"to satisfy tax withholding obligations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ACH shares did the CFO surrender for tax withholding?

Leon Jonathan A, Accendra Health's EVP & CFO, surrendered 4,265 shares to the issuer on September 23, 2026, to satisfy tax withholding obligations tied to vesting of restricted stock. The reported price was $0.85 per share, and he held 286,268 shares directly after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 04:32 PM Accepted by SEC EDGAR 09/24/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leon Jonathan A

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/23/2026		F		4,265(1)	D	$0.85	286,268	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Jonathan A. Leon, by Rosemarie W. France POA	09/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)